The CRIION Joachim Frank Prize 2026, presented by the Comprehensive Research Institute for Integrative Oncology (CRIION) Freiburg, recognizes outstanding achievements in cancer research. Prof. Robert Zeiser (B09, B10) was honored for his pioneering contributions to the understanding and treatment of immune-mediated diseases, particularly in the context of graft-versus-host disease and cancer immunotherapy.
As a principal investigator within SFB 1160, Prof. Zeiser’s work has significantly advanced our understanding of immune cell adaptation and regulation in inflammatory environments. His research bridges fundamental immunology and clinical application, contributing to the development of innovative therapeutic strategies.
This award highlights the excellence of cancer and immunology research in Freiburg and underscores the strong collaborative environment fostered within SFB 1160.
